Bubs Australia extends rally after infant formulas get US FDA approval
08/09/2026 02:32
BUZZ-Bubs Australia extends rally after infant formulas get US FDA approval ** Shares of Bubs Australia BUB.AX rise as much as 7.7% to A$0.140, after soaring 30% on Monday
** Co on Monday revealed that its Bubs Goat, Bubs 365 Day Grass Fed and Bubs Essential infant formula products secured permanent U.S. FDA approval
** Shares set for seven straight days of gains
** YTD, BUB shares down 1.8%
(Reporting by Nichiket Sunil in Bengaluru)
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump